AbbVie (ABBV) Accounts Payables (2012 - 2026)
AbbVie (ABBV) posted Accounts Payables of $33.3 billion for Q2 2026, up 3.3% from $32.25 billion a year earlier but down 1.4% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Accounts Payables (2012 - 2026) Analysis & Trends
At the end of FY2025, AbbVie's Accounts Payables came in at $34.73 billion, up 8.7% from FY2024.
- Annual Accounts Payables has increased for six consecutive years, with a five-year compound annual growth rate of 11.5% (FY2020 to FY2025).
- In prior years, AbbVie's Accounts Payables was $31.95 billion in FY2024 (+4.2%), $30.65 billion in FY2023 (+20.7%), $25.4 billion in FY2022 (+11.9%) and $22.7 billion in FY2021 (+12.6%).
- Quarterly Accounts Payables has run from a low of $21.86 billion in Q3 2021 to a high of $34.73 billion in Q4 2025 over five years.
- On a year-over-year basis, Accounts Payables has increased in each of the last five quarters, with growth averaging 5.9% over the last eight quarters.
- The strongest year-over-year quarter for Accounts Payables in the past five years was Q1 2024, with growth of 26.4%; the weakest was Q1 2025, with a decline of 0.9%.
- According to Business Quant data, Accounts Payables for the three prior quarters was $33.77 billion (Q1 2026), $34.73 billion (Q4 2025) and $33.62 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn | 4.16 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.30 Bn |
| Mar 31, 2026 | 33.77 Bn |
| Dec 31, 2025 | 34.73 Bn |
| Sep 30, 2025 | 33.62 Bn |
| Jun 30, 2025 | 32.25 Bn |
| Mar 31, 2025 | 31.04 Bn |
| Dec 31, 2024 | 31.95 Bn |
| Sep 30, 2024 | 30.49 Bn |
| Jun 30, 2024 | 29.33 Bn |
| Mar 31, 2024 | 31.33 Bn |
| Dec 31, 2023 | 30.65 Bn |
| Sep 30, 2023 | 29.66 Bn |
| Jun 30, 2023 | 27.04 Bn |
| Mar 31, 2023 | 24.79 Bn |
| Dec 31, 2022 | 25.40 Bn |
| Sep 30, 2022 | 23.51 Bn |
| Jun 30, 2022 | 22.54 Bn |
| Mar 31, 2022 | 22.57 Bn |
| Dec 31, 2021 | 22.70 Bn |
| Sep 30, 2021 | 21.86 Bn |
API Access
AbbVie Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();